Medical Center Kordis OOD
- Address
- Ulitsa Sveti Sveti Kiril I Metodiy 21, 5800 Pleven, Bulgaria
Cardiovascular Diseases
At Medical Center Kordis OOD investigators are exploring new approaches to manage high blood pressure that does not respond to standard therapy.
- Uncontrolled hypertension
- Resistant hypertension
The studies aim to determine the efficacy of novel oral agents in reducing systolic blood pressure. They also evaluate the safety profile of these treatments for patients with difficult‑to‑control hypertension.
Immune System Diseases
Research at the site focuses on immune‑mediated skin conditions, seeking better therapeutic options for patients who require systemic treatment.
- Atopic dermatitis
- Hidradenitis suppurativa
- Non‑segmental vitiligo
Trials compare emerging biologics and small molecules to existing standards, assessing their efficacy in achieving skin clearance. They also monitor the safety of these agents for long‑term use.
Skin and Connective Tissue Diseases
The department conducts a broad program addressing chronic inflammatory skin disorders, aiming to improve quality of life for affected individuals.
- Moderate to severe plaque psoriasis
- Atopic dermatitis
- Hidradenitis suppurativa
- Non‑segmental vitiligo
The goal is to demonstrate enhanced efficacy compared with current treatments. Researchers also track the safety and patient‑reported outcomes throughout the study.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1AbbVie Deutschland GmbH & Co. KG1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AbbVie Deutschland GmbH & Co. KG4trials
lock +4 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical Center Kordis OOD
lock Showing 1 of 14 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicenter, randomized, participant- and investigator -blinded, placebo-controlled, phase 2a study to assess the efficacy, safety and tolerability of GIA632 in adult participants with moderate to severe atopic dermatitis | Novartis Pharma AG | Phase II | Not Yet Recruiting | Feb 2026 | — |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Upadacitinib | 3 | Unknown | 2023-05-31 | 2024-12-03 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.